Glial cells could be the key in therapy against neurodegenerative diseases
IDIBELL participates in a European project of rare diabetes syndromes
IDIBELL participates in the Euro Rare Diabetes Project, which was founded with the goal of creating a register of rare diabetes syndromes to increase knowledge about these diseases and to promote translational research.
Manel Esteller, new Faculty 1000 member
Created in 2002, 1000 Faculty appears as a new space on the network for the assessment of scientific research papers. It features the opinions of leading international researchers in life sciences.
Paper published by IDIBELL researchers is the world's most influential in biology, according to Science Watch
The article, “Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis”, was published on March 2009 in Cancer Cell, one of the most prestigious journals on cancer research.
A new gene involved in lung cancer, identified in patients
Thanks to these advances, a study led by researchers from the research group of Genes and Cancer at the Epigenetics and Biology Program Cancer Biomedical Research of Bellvitge Biomedical Research Institute (IDIBELL) identified for the first time in primary tumour tissue from lung cancer patients the